Takihiro Inaba

T-614, a Novel Antirheumatic Drug, Inhibits Both the Activity and Induction of Cyclooxygenase-2 (COX-2) in Cultured Fibroblasts

Keiichi Tanaka, Hiroki Kawasaki, Kiyonobu Kurata et al. · The Japanese Journal of Pharmacology · 1995 · 75 citations · Full text

Pge2 Production, Lipid Peroxidation, Immunology +18

Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.

K. Tanaka, T Shimotori, Shinji Makino et al. · PubMed · 1992 · 62 citations

Antiparasitic Agent, Pain Medicine, Immunology +18

Synthesis and Antiinflammatory Activity of 7-Methanesulfonylamino-6-phenoxychromones. Antiarthritic Effect of the 3-Formylamino Compound (T-614) in Chronic Inflammatory Disease Models.

Takihiro Inaba, Kéiichi Tanaka, RYUKO TAKENO et al. · Chemical and Pharmaceutical Bulletin · 2000 · 58 citations · Full text

Pharmacological Studies on 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a Novel Antiinflammatory Agent. 4th Communication: Inhibitory Effect on the Production of Interleukin-1 and Interleukin-6.

Kéiichi Tanaka, Yukihiko Aikawa, Hiroki Kawasaki et al. · Journal of Pharmacobio-Dynamics · 1992 · 40 citations · Full text

Thp-1 Cells, Immunotoxicology, Immunology +17

Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4'-1-benzopyran-4-o ne. 2nd communication: effect on the arachidonic acid cascades.

K. Tanaka, Shinji Makino, T Shimotori et al. · PubMed · 1992 · 25 citations

Pge2 Contents, Antiparasitic Agent, Pge2 Generation +18